| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +2.14% | +0.41% | +1.74% | +1.74% | — |
| 14d | 1 | +100.00% | -33.71% | -9.10% | -24.61% | -24.61% | — |
| 30d | 1 | +100.00% | -10.26% | -11.16% | +0.90% | +0.90% | — |
| 60d | 1 | +100.00% | -9.36% | -2.99% | -6.37% | -6.37% | — |
| 90d | 1 | +0.00% | +29.76% | +2.86% | +26.90% | +26.90% | — |
| 180d | 1 | +0.00% | +14.32% | +18.52% | -4.21% | -4.21% | — |
| 1y | 1 | +100.00% | -60.99% | +30.79% | -91.78% | -91.78% | — |
| 2y | 1 | +100.00% | -75.65% | +52.14% | -127.79% | -127.79% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| AKBA AKEBIA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 88,133 | Feb 28, 2020 | Mar 2, 2020 ↗ | View → |
| AKBA AKEBIA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 85,000 | — | — | 85,000 | Feb 28, 2020 | Mar 2, 2020 ↗ | View → |
| AKBA AKEBIA THERAPEUTICS, INC. | SALE SVP, Chief Development Officer | 3,454 | $8.70 | $30.0K | 84,679 | Feb 28, 2020 | Mar 2, 2020 ↗ | View → |